But keep in mind, there is value in the underlying Intellectual Property and Patents.
It then becomes a matter of identifying the potential application of that IP and Patent.
I think the real opportunity for GTG at the moment is to get momentum with their Multi-test product and tap into government subsidised funding, as preventative medicine will save governments lots of money. So GTG management need to build better relationships and/or employ people with those established relationships.
Hopefully EasyDNA will also give them some more global visibility and opportunity for increased sales.
GTG Price at posting:
0.5¢ Sentiment: None Disclosure: Held
